Johnson & Johnson (NYSE: JNJ) reported Q3 EPS of $2.80, $0.04 better than the analyst estimate of $2.76. Revenue for the quarter came in at $23.99 billion versus the consensus estimate of $23.76 billion.

GUIDANCE:

Johnson & Johnson sees FY2025 EPS of $10.80-$10.90, versus the consensus of $10.85. Johnson & Johnson sees FY2025 revenue of $93.5-93.9 billion, versus the consensus of $93.46 billion.

For earnings history and earnings-related data on Johnson & Johnson (JNJ) click here.